MNKD

MannKind
MNKD

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.40B
EV
$1.35B
Shares Outstanding
307.78M
Beta
1.21

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$10.29
P/E 2025E
26.09x
P/Revenue 2025E
4.41x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About MannKind Corporation

gainify
MNKD

MannKind Corporation

MNKD

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in a...

Sector

Healthcare

Industry

Biotechnology

CEO

Castagna, Michael

Employees

405

IPO Date

2004-07-28

Headquarters

1 Casper Street, Danbury, Connecticut, 06810, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved